Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

1Total

P 1 (1)

Trial Status

Enrolling By Invitation2

Recruiting1

Completed1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 1 completed trials

Clinical Trials (4)

Showing 4 of 4 trials

NCT01803906Enrolling By Invitation

Tissue Sample Study for Mitochondrial Disorders

NCT05554835Recruiting

Global Registry and Natural History Study for Mitochondrial Disorders

NCT06376279Enrolling By Invitation

Genetic Diagnosis in Inborn Errors of Metabolism

NCT02544217Phase 1Completed

A Dose-escalating Clinical Trial With KH176

Showing all 4 trials

LHON